New study suggests that an experimental peptide developed at the Hebrew University may reduce recurring seizures and support brain function by targeting underlying oxidative stress and inflammation processes linked to epilepsy. Unlike current treatments that focus mainly on suppressing seizures, this approach could influence how the disease develops over time, with the greatest benefits appearing when treatment begins early. The findings point to a promising direction for future therapies aimed at improving long-term outcomes for people living with epilepsy.
The Hebrew University of Jerusalem is proud to congratulate Prof. Benjamin Weiss of the Einstein Institute for Mathematics on being awarded the Israel Prize in the field of mathematics, computer science, and computer engineering research.
